Logo image of ALECP.PA

EUROPACORP (ALECP.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALECP - FR0010490920 - Common Stock

0.425 EUR
0 (0%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALECP. ALECP was compared to 48 industry peers in the Entertainment industry. ALECP has a bad profitability rating. Also its financial health evaluation is rather negative. ALECP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ALECP has reported negative net income.
  • In the past year ALECP had a positive cash flow from operations.
  • Of the past 5 years ALECP 4 years were profitable.
  • ALECP had a positive operating cash flow in each of the past 5 years.
ALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • ALECP has a Return On Assets of -2.37%. This is comparable to the rest of the industry: ALECP outperforms 47.92% of its industry peers.
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROIC N/A
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALECP.PA Yearly ROA, ROE, ROICALECP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K 15K

1.3 Margins

  • ALECP has a worse Gross Margin (22.50%) than 85.42% of its industry peers.
  • ALECP's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALECP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
ALECP.PA Yearly Profit, Operating, Gross MarginsALECP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200

2

2. Health

2.1 Basic Checks

  • ALECP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALECP has more shares outstanding
  • ALECP has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALECP has about the same debt to assets ratio.
ALECP.PA Yearly Shares OutstandingALECP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALECP.PA Yearly Total Debt VS Total AssetsALECP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • ALECP has an Altman-Z score of -2.33. This is a bad value and indicates that ALECP is not financially healthy and even has some risk of bankruptcy.
  • ALECP has a worse Altman-Z score (-2.33) than 85.42% of its industry peers.
  • ALECP has a debt to FCF ratio of 28.76. This is a negative value and a sign of low solvency as ALECP would need 28.76 years to pay back of all of its debts.
  • ALECP's Debt to FCF ratio of 28.76 is on the low side compared to the rest of the industry. ALECP is outperformed by 64.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Altman-Z -2.33
ROIC/WACCN/A
WACC5.14%
ALECP.PA Yearly LT Debt VS Equity VS FCFALECP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

2.3 Liquidity

  • ALECP has a Current Ratio of 1.16. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.16, ALECP is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Quick Ratio of 1.16 indicates that ALECP should not have too much problems paying its short term obligations.
  • ALECP's Quick ratio of 1.16 is fine compared to the rest of the industry. ALECP outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
ALECP.PA Yearly Current Assets VS Current LiabilitesALECP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • The Revenue has been growing slightly by 1.89% in the past year.
  • Measured over the past years, ALECP shows a very negative growth in Revenue. The Revenue has been decreasing by -14.67% on average per year.
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%

3.2 Future

  • The Earnings Per Share is expected to decrease by -38.96% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -35.46% on average over the next years. This is quite bad
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALECP.PA Yearly Revenue VS EstimatesALECP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALECP.PA Yearly EPS VS EstimatesALECP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5 -2

3

4. Valuation

4.1 Price/Earnings Ratio

  • ALECP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 9.31, the valuation of ALECP can be described as very reasonable.
  • 95.83% of the companies in the same industry are more expensive than ALECP, based on the Price/Forward Earnings ratio.
  • ALECP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
Industry RankSector Rank
PE N/A
Fwd PE 9.31
ALECP.PA Price Earnings VS Forward Price EarningsALECP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALECP indicates a somewhat cheap valuation: ALECP is cheaper than 75.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALECP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.43
EV/EBITDA 6.32
ALECP.PA Per share dataALECP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

  • ALECP's earnings are expected to decrease with -38.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ALECP!.
Industry RankSector Rank
Dividend Yield 0%

EUROPACORP

EPA:ALECP (1/16/2026, 7:00:00 PM)

0.425

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)12-11
Earnings (Next)05-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap53.30M
Revenue(TTM)33.99M
Net Income(TTM)-1.94M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.31
P/S 1.57
P/FCF 26.43
P/OCF 3.42
P/B N/A
P/tB N/A
EV/EBITDA 6.32
EPS(TTM)-0.02
EYN/A
EPS(NY)0.05
Fwd EY10.74%
FCF(TTM)0.02
FCFY3.78%
OCF(TTM)0.12
OCFY29.26%
SpS0.27
BVpS-0.03
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.5%
FCFM 5.93%
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Debt/EBITDA 2.53
Cap/Depr 74.8%
Cap/Sales 39.95%
Interest Coverage N/A
Cash Conversion 88.56%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z -2.33
F-Score5
WACC5.14%
ROIC/WACCN/A
Cap/Depr(3y)110.61%
Cap/Depr(5y)70.32%
Cap/Sales(3y)61.29%
Cap/Sales(5y)38.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.59%
OCF growth 3Y0.62%
OCF growth 5Y-7.81%

EUROPACORP / ALECP.PA FAQ

What is the fundamental rating for ALECP stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALECP.PA.


What is the valuation status for ALECP stock?

ChartMill assigns a valuation rating of 3 / 10 to EUROPACORP (ALECP.PA). This can be considered as Overvalued.


Can you provide the profitability details for EUROPACORP?

EUROPACORP (ALECP.PA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for EUROPACORP?

The Earnings per Share (EPS) of EUROPACORP (ALECP.PA) is expected to decline by -49.12% in the next year.


Can you provide the dividend sustainability for ALECP stock?

The dividend rating of EUROPACORP (ALECP.PA) is 0 / 10 and the dividend payout ratio is 0%.